Will Bionano Genomics (BNGO) Stock See A Dead Cat Bounce In April?

Over the course of the past year, the genomics sector has managed to attract significant attention from investors and many of the stocks in the sector have also recorded considerable gains.

Bionano Genomics (NASDAQ: BNGO) is among the stock to have benefitted from this trend. The company is involved in the life sciences industry and is working at the forefront of the genetics analysis space. Over the course of the past three months alone, the stock has gone up by as much as 160%.

Related:  Elite Pharmaceuticals (ELTP) Gains Momentum on Huge Volume: What to do Now?

In such a situation, it might be a good idea for investors to perhaps start tracking the stock closely. That being said, it is also necessary to point out that the stock has declined by around 17% since March 15, 2021. The recent fall could in fact prove to be an opportunity for investors who want to get into the Bionano stock. Investors could consider keeping an eye on any news in relation to Bionano.

Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.